iodixanol has been researched along with Cancer of Liver in 26 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purposes of this study were to evaluate the effect of contrast material flow rate (3 mL/sec vs 5 mL/sec) on the detection and visualization of hepatocellular carcinoma (HCC) with MDCT and the safety profile of iodixanol at different injection rates." | 5.12 | Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. ( Bellomi, M; Brisbois, D; Catalano, C; Chevallier, P; Dirisamer, A; Dobritz, M; Drouillard, J; Fraioli, F; Hammerstingl, R; Jesus Martinez, M; Marti-Bonmati, L; Montero, FT; Morassut, S; Rummeny, EJ; Schima, W; Vogl, TJ; Westermayer, B, 2006) |
| "We have developed and optimized a rapid iodixanol (OptiPrep)-based gradient centrifugation system to identify, isolate and characterize doxorubicin (DXR)-induced senescent hepatocellular carcinoma (HCC) cells (HepG2 and Huh-7) in vitro." | 3.91 | Isolation of senescent cells by iodixanol (OptiPrep) density gradient-based separation. ( Kovacovicova, K; Vinciguerra, M, 2019) |
| "SRFA allowed for efficient, reliable, and safe ablation of large-volume liver disease." | 1.38 | Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance. ( Bale, R; Haidu, M; Schullian, P; Widmann, G, 2012) |
| "The purpose of this study was to assess whether portal vein embolization (PVE) using a nitinol vascular plug in combination with histoacryl glue and iodinized oil minimizes the risk of nontarget embolization while obtaining good levels of future liver remnant (FLR) hypertrophy." | 1.35 | Portal vein embolization using a nitinol plug (Amplatzer vascular plug) in combination with histoacryl glue and iodinized oil: adequate hypertrophy with a reduced risk of nontarget embolization. ( Bent, CL; Fotheringham, T; Low, D; Matson, MB; Renfrew, I, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (26.92) | 29.6817 |
| 2010's | 19 (73.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kovacovicova, K | 1 |
| Vinciguerra, M | 1 |
| Jhaveri, KS | 2 |
| Fischer, SE | 1 |
| Hosseini-Nik, H | 1 |
| Sreeharsha, B | 1 |
| Menezes, RJ | 1 |
| Gallinger, S | 1 |
| Moulton, CE | 1 |
| Li, W | 1 |
| Li, A | 1 |
| Wang, B | 1 |
| Niu, X | 1 |
| Cao, X | 1 |
| Wang, X | 1 |
| Shi, H | 1 |
| Albrecht, MH | 1 |
| Vogl, TJ | 2 |
| Wichmann, JL | 1 |
| Martin, SS | 1 |
| Scholtz, JE | 1 |
| Fischer, S | 2 |
| Hammerstingl, RM | 1 |
| Harth, M | 1 |
| Nour-Eldin, NA | 1 |
| Thalhammer, A | 1 |
| Zangos, S | 1 |
| Bauer, RW | 1 |
| Andersen, IR | 1 |
| Olesen, R | 1 |
| Boysen, AK | 1 |
| Jensen, LH | 1 |
| Mortensen, FV | 1 |
| Nielsen, DT | 1 |
| Rasmussen, F | 1 |
| Wong, AA | 1 |
| Charalel, RA | 1 |
| Louie, JD | 1 |
| Sze, DY | 1 |
| Jang, HJ | 2 |
| Kim, TK | 2 |
| Khalili, K | 1 |
| Yazdi, L | 1 |
| Menezes, R | 1 |
| Park, SH | 1 |
| Sherman, M | 1 |
| Ierardi, AM | 1 |
| Floridi, C | 1 |
| Fontana, F | 1 |
| Chini, C | 1 |
| Giorlando, F | 1 |
| Piacentino, F | 1 |
| Brunese, L | 2 |
| Pinotti, G | 1 |
| Bacuzzi, A | 1 |
| Carrafiello, G | 1 |
| Vandecaveye, V | 1 |
| Michielsen, K | 1 |
| De Keyzer, F | 1 |
| Laleman, W | 1 |
| Komuta, M | 1 |
| Op de beeck, K | 1 |
| Roskams, T | 1 |
| Nevens, F | 1 |
| Verslype, C | 1 |
| Maleux, G | 1 |
| van den Hoven, AF | 1 |
| Prince, JF | 1 |
| de Keizer, B | 1 |
| Vonken, EJ | 1 |
| Bruijnen, RC | 1 |
| Verkooijen, HM | 1 |
| Lam, MG | 1 |
| van den Bosch, MA | 1 |
| Rose, SC | 1 |
| Kikolski, SG | 1 |
| Morshedi, MM | 1 |
| Narsinh, KH | 1 |
| Bent, CL | 1 |
| Low, D | 1 |
| Matson, MB | 1 |
| Renfrew, I | 1 |
| Fotheringham, T | 1 |
| Scialpi, M | 1 |
| Volterrani, L | 1 |
| Mazzei, MA | 1 |
| Cappabianca, S | 1 |
| Barberini, F | 1 |
| Piscioli, I | 1 |
| Lupattelli, L | 1 |
| Halankar, J | 1 |
| Aguirre, D | 1 |
| Haider, M | 1 |
| Lockwood, G | 1 |
| Guindi, M | 1 |
| Deschamps, F | 1 |
| Solomon, SB | 1 |
| Thornton, RH | 1 |
| Rao, P | 1 |
| Hakime, A | 1 |
| Kuoch, V | 1 |
| de Baere, T | 1 |
| Kim, HC | 1 |
| Chung, JW | 1 |
| Jae, HJ | 1 |
| Yoon, JH | 1 |
| Lee, JH | 1 |
| Kim, YJ | 1 |
| Lee, HS | 1 |
| Yoon, CJ | 1 |
| Park, JH | 1 |
| Bouvier, A | 1 |
| Ozenne, V | 1 |
| Aubé, C | 1 |
| Boursier, J | 1 |
| Vullierme, MP | 1 |
| Thouveny, F | 1 |
| Farges, O | 1 |
| Vilgrain, V | 1 |
| Schullian, P | 2 |
| Widmann, G | 2 |
| Lang, TB | 1 |
| Knoflach, M | 1 |
| Bale, R | 2 |
| Haidu, M | 1 |
| Alturkistany, S | 1 |
| Yu, H | 1 |
| Lee, KH | 1 |
| Golowa, YS | 1 |
| Cynamon, J | 1 |
| Reinus, JF | 1 |
| Kinkhabwala, M | 1 |
| Abrams, M | 1 |
| Jagust, M | 1 |
| Chernyak, V | 1 |
| Kaubisch, A | 1 |
| Bova, V | 1 |
| Miraglia, R | 1 |
| Maruzzelli, L | 1 |
| Vizzini, GB | 1 |
| Luca, A | 1 |
| Schima, W | 1 |
| Hammerstingl, R | 1 |
| Catalano, C | 1 |
| Marti-Bonmati, L | 1 |
| Rummeny, EJ | 1 |
| Montero, FT | 1 |
| Dirisamer, A | 1 |
| Westermayer, B | 1 |
| Bellomi, M | 1 |
| Brisbois, D | 1 |
| Chevallier, P | 1 |
| Dobritz, M | 1 |
| Drouillard, J | 1 |
| Fraioli, F | 1 |
| Jesus Martinez, M | 1 |
| Morassut, S | 1 |
| Christova, T | 1 |
| Templeton, DM | 1 |
| Larsen, LP | 1 |
| Rosenkilde, M | 1 |
| Christensen, H | 1 |
| Bang, N | 1 |
| Bolvig, L | 1 |
| Christiansen, T | 1 |
| Laurberg, S | 1 |
| Graham, JM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective Study Evaluating Diagnostic Accuracy, Outcome, and Economic Impact of Abbreviated Gadoxetate-enhanced MRI of the Liver in Patients With Metastatic Colorectal Carcinoma[NCT05314400] | 300 participants (Anticipated) | Interventional | 2022-07-01 | Recruiting | |||
| Interobserver Agreement of Determination of Hepatocellular Carcinoma Feeding Vessels : Multi-Detector CT Angiography With 3D Reconstruction Versus Digital Subtraction Angiography[NCT05304572] | 70 participants (Actual) | Observational | 2022-05-01 | Completed | |||
| Stereotactic Image-Guided Microwave Ablation for Hepatocellular Carcinoma - Does Computer-assistance Broaden Eligibility and Efficacy of Ablative Treatment?[NCT03630068] | 87 participants (Actual) | Observational | 2015-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for iodixanol and Cancer of Liver
| Article | Year |
|---|---|
Automatic spectral imaging protocol and iterative reconstruction for radiation dose reduction in typical hepatic hemangioma computed tomography with reduced iodine load: a preliminary study.
Topics: Adult; Contrast Media; Female; Hemangioma; Humans; Iopamidol; Liver Neoplasms; Male; Middle Aged; Pr | 2018 |
Dynamic 4D-CT Angiography for Guiding Transarterial Chemoembolization: Impact on the Reduction of Contrast Material, Operator Radiation Exposure, Catheter Consumption, and Diagnostic Confidence.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Catheters; Chemoembolizatio | 2018 |
Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prosp | 2006 |
23 other studies available for iodixanol and Cancer of Liver
| Article | Year |
|---|---|
Isolation of senescent cells by iodixanol (OptiPrep) density gradient-based separation.
Topics: Carcinoma, Hepatocellular; Cell Separation; Cellular Senescence; DNA Damage; Doxorubicin; Humans; Li | 2019 |
Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Chemotherapy, Adjuvant; Clinical Decision-Making; Colorectal | 2017 |
Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib.
Topics: Abdominal Neoplasms; Aged; Biomarkers; Colorectal Neoplasms; Contrast Media; Female; Four-Dimensiona | 2019 |
Carbon dioxide contrast enhancement for C-arm CT utility for treatment planning during hepatic embolization procedures.
Topics: Aged; Aged, 80 and over; Carbon Dioxide; Cone-Beam Computed Tomography; Contrast Media; Embolization | 2013 |
Characterization of 1-to 2-cm liver nodules detected on hcc surveillance ultrasound according to the criteria of the American Association for the Study of Liver Disease: is quadriphasic CT necessary?
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Neoplasms; Logistic Mo | 2013 |
Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation.
Topics: Aged; Aged, 80 and over; Catheter Ablation; Colorectal Neoplasms; Contrast Media; Disease-Free Survi | 2013 |
Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diffusion | 2014 |
Use of C-Arm Cone Beam CT During Hepatic Radioembolization: Protocol Optimization for Extrahepatic Shunting and Parenchymal Enhancement.
Topics: Aged; Aged, 80 and over; Collateral Circulation; Cone-Beam Computed Tomography; Contrast Media; Fema | 2016 |
Feasibility of Intraprocedural Transluminal Hepatic and Femoral Artery Blood Pressure Measurements as an Alternative Embolization Safety Endpoint When Antireflux Devices Are Used During Lobar Chemoembolization.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antineoplastic Agents; Blood Pressure; Ca | 2015 |
Portal vein embolization using a nitinol plug (Amplatzer vascular plug) in combination with histoacryl glue and iodinized oil: adequate hypertrophy with a reduced risk of nontarget embolization.
Topics: Angiography; Combined Modality Therapy; Contrast Media; Embolization, Therapeutic; Enbucrilate; Fema | 2009 |
Small (< or = 2 cm) atypical hepatic haemangiomas in the non-cirrhotic patient: pattern-based classification scheme for enhancement at triple-phase helical CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Female; Hemangioma; Humans; | 2009 |
Intrahepatic bile duct dilatation due to liver metastases from colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Chi-Square Dist | 2009 |
Computed analysis of three-dimensional cone-beam computed tomography angiography for determination of tumor-feeding vessels during chemoembolization of liver tumor: a pilot study.
Topics: Adult; Aged; Angiography; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cone-Beam Compu | 2010 |
Caudate lobe hepatocellular carcinoma treated with selective chemoembolization.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Doxorubicin; | 2010 |
Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival.
Topics: Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Eth | 2011 |
Accuracy and diagnostic yield of CT-guided stereotactic liver biopsy of primary and secondary liver tumors.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Biopsy; Contrast Media; Female; Humans; Imaging, Three-D | 2011 |
Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female | 2012 |
Fading hepatic hemangiomas on multiphasic CT.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Contrast Media; Female; Gadolinium DTPA; He | 2012 |
Value of noncontrast CT immediately after transarterial chemoembolization of hepatocellular carcinoma with drug-eluting beads.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Med | 2012 |
Predictive factors of downstaging of hepatocellular carcinoma beyond the Milan criteria treated with intra-arterial therapies.
Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Contrast | 2013 |
Effect of hypoxia on the binding and subcellular distribution of iron regulatory proteins.
Topics: Animals; Calcium; Carcinoma, Hepatocellular; Cell Fractionation; Cell Line; Endoplasmic Reticulum; H | 2007 |
Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer?
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Humans; Liver Neoplasms; Middl | 2009 |
Isolation of peroxisomes from tissues and cells by differential and density gradient centrifugation.
Topics: Animals; Biomarkers; Carcinoma, Hepatocellular; Cell Fractionation; Cell Line, Tumor; Centrifugation | 2001 |